Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-131928
Filing Date
2026-03-30
Accepted
2026-03-30 17:34:03
Documents
91
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rnxt-20251231.htm   iXBRL 10-K 3501849
2 EX-23.1 rnxt-ex23_1.htm EX-23.1 3333
3 EX-31.1 rnxt-ex31_1.htm EX-31.1 16772
4 EX-31.2 rnxt-ex31_2.htm EX-31.2 16904
5 EX-32.1 rnxt-ex32_1.htm EX-32.1 8761
6 EX-32.2 rnxt-ex32_2.htm EX-32.2 8816
7 GRAPHIC img28029992_0.jpg GRAPHIC 208086
8 GRAPHIC img28029992_1.jpg GRAPHIC 35856
9 GRAPHIC img28029992_2.jpg GRAPHIC 112262
10 GRAPHIC img28029992_3.jpg GRAPHIC 18602
11 GRAPHIC img28029992_4.jpg GRAPHIC 120094
12 GRAPHIC img28029992_5.jpg GRAPHIC 82459
13 GRAPHIC img28029992_6.jpg GRAPHIC 35907
  Complete submission text file 0001193125-26-131928.txt   13598010

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnxt-20251231.xsd EX-101.SCH 1346747
95 EXTRACTED XBRL INSTANCE DOCUMENT rnxt-20251231_htm.xml XML 2211463
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40738 | Film No.: 26813494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)